Released Jun 14, 2016, after the close
10-Q filed Jun 14, 2016, 45 days after period end · 0001354488-16-007822
Q2 2016 · 10-Q
Revenue—
Net Income$37.20K$37.20K −89.6% vs Q2 2015−89.4% vs Q1 2016
EPS Diluted$0.00$0.00 −86.7% vs Q2 2015−86.7% vs Q1 2016
Gross Profit$1,524,157−9.6%
Operating Income$94,637−75.9%
Operating Cash Flow$129,971N/M
Free Cash Flowderived-$77,487N/M
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q2 2016 | Q2 2015 | Q2 2014 | Q2 2013 |
|---|---|---|---|---|
| Net Income | $37.20K | $359.01K | $327.78K | $1.39M |
| EPS Diluted | $0.00 | $0.02 | $0.01 | $0.06 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pharma-Bio Serv, Inc. · CIK 1304161 · Engraved from SEC EDGAR